FDA Inspection
Towa Pharmaceutical Europe, S.L.Towa Pharmaceutical Europe, S.L. – FDA Inspection, Mar 31, 2017
Record Details
This FDA Inspection record concerns Towa Pharmaceutical Europe, S.L., with an inspection on March 31, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9948e85f-5b91-4a1e-998a-3e96ca2da81e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1018727
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Towa Pharmaceutical Europe, S.L.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 18, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 10, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 19, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Towa Pharmaceutical Europe, S.L.
- FDA Inspection 1180157 - 2022-09-09
- FDA Inspection 1100280 - 2019-01-18
- FDA Inspection 917425 - 2015-02-13
- FDA Inspection 835225 - 2013-05-10
- FDA Inspection 658164 - 2010-02-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.